title: [Selegiline in Parkinson's disease; symptomatic or causal effect?].
authors.affiliation: Academisch Ziekenhuis Vrije Universiteit, afd. Neurologie, Amsterdam.
authors.forename: E C
authors.initials: EC
authors.lastname: Wolters
authors.forename: M A
authors.initials: MA
authors.lastname: Kuiper
authors.forename: M W
authors.initials: MW
authors.lastname: Horstink
mesh_terms: D004734:Energy Metabolism; D005609:Free Radicals; D006801:Humans; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000172:deficiency; D010084:Oxidation-Reduction; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D012642:Selegiline / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D005609:Free Radicals; D012642:Selegiline; D016660:NAD(P)H Dehydrogenase (Quinone)
vernacular_title: Selegiline bij de ziekte van Parkinson; symptomatisch of causaal effect?